Steven Coen succeeds Dmytruk as CFO of Ginkgo

Mark Dmytruk will resign as CFO of Ginkgo Bioworks Holdings Inc. (NYSE:DNA) on May 30 to join another organization. Chief Accounting Officer Steven Coen, who joined the company in 2023, will succeed Dmytruk. Ginkgo is developing platforms for cell programming and biosecurity. 

Ed Savory became head of chemistry at Slingshot Therapeutics Ltd., a Syncona-backed incubator in-licensing small molecules for inflammation. Savory was most recently SVP of drug discovery at Benevolentai S.A. ...